44 studies found for:    "Short bowel syndrome"
Show Display Options
Rank Status Study
1 Unknown  Pharmacokinetics of Citalopram in Patients With Short Bowel Syndrome
Condition: Short Bowel Syndrome
Intervention: Drug: Citalopram
2 Active, not recruiting A Prospective, Multi-center Registry for Patients With Short Bowel Syndrome
Condition: Short Bowel Syndrome
Intervention:
3 Withdrawn Fiber Use in Pediatric Short Bowel Syndrome
Condition: Short Bowel Syndrome
Intervention: Dietary Supplement: guar gum
4 Completed
Has Results
Safety and Efficacy Study of Teduglutide in Subjects With Short Bowel Syndrome
Condition: Short Bowel Syndrome
Interventions: Drug: Placebo;   Drug: Teduglutide 0.05 mg/kg/d;   Drug: Teduglutide 0.1 mg/kg/d
5 Recruiting Energy Metabolism in Patients With Short Bowel Syndrome
Condition: Short Bowel Syndrome
Intervention:
6 Enrolling by invitation Effect of the Enteric Hormone Glucagon-Like Peptide (GLP-2) on the Intestinal Blood Flow in Patients With Short Bowel Syndrome
Condition: Short Bowel Syndrome
Interventions: Drug: GLP-2;   Drug: Placebo
7 Completed Evaluation of the Efficacy and Safety of Recombinant Human Growth Hormone (rhGH) in the Treatment of Children With Short Bowel Syndrome
Condition: Short Bowel Syndrome
Intervention: Drug: rhGH
8 Recruiting Enteral Glutamine in Reducing Bloodstream Infections in Short Bowel Syndrome Infants
Conditions: Bloodstream Infections;   Short Bowel Syndrome;   Development;   Nutrition;   Biological Markers
Interventions: Drug: Glutamine;   Dietary Supplement: L-alanine
9 Completed
Has Results
Study of Teduglutide Effectiveness in Parenteral Nutrition (PN)-Dependent Short Bowel Syndrome (SBS) Subjects
Condition: Short Bowel Syndrome
Interventions: Drug: teduglutide;   Drug: placebo
10 Recruiting A Pharmacokinetic, Safety, and Pharmacodynamic Study of Teduglutide in Pediatric Subjects With Short Bowel Syndrome
Condition: Short Bowel Syndrome
Intervention: Drug: teduglutide
11 Terminated Evaluate the Efficacy and Safety Growth Hormone, Glutamine and Diet in Patients With Short Bowel Syndrome (SBS)
Condition: Short Bowel Syndrome
Intervention: Drug: Growth Hormone
12 Completed Open-Label Study of Teduglutide for Subjects With PN-Dependent Short Bowel Syndrome (SBS)
Condition: Short Bowel Syndrome
Intervention: Drug: teduglutide
13 Completed
Has Results
Safety and Efficacy Study of Teduglutide in Subjects With Short Bowel Syndrome Who Completed Protocol CL0600-004 (NCT00081458)
Condition: Short Bowel Syndrome
Interventions: Drug: teduglutide 0.05 mg/kg/d;   Drug: teduglutide 0.10 mg/kg/d
14 Withdrawn Exenatide on GI Motor Function and Permeability in Short Bowel Syndrome
Condition: Short Bowel Syndrome
Interventions: Drug: Exenatide;   Drug: Placebo
15 Active, not recruiting Short Bowel Syndrome and Teduglutide VS Placebo
Condition: Short Bowel Syndrome
Interventions: Drug: Teduglutide;   Drug: Placebo
16 Active, not recruiting Safety and Immunogenicity of Rotavirus Vaccine (RotaTeq(R)) in Infants With Short Bowel Syndrome
Condition: Short Bowel Syndrome
Intervention: Biological: Oral, live, pentavalent rotavirus vaccine; RotaTeq(R)
17 Recruiting The Preventative and Therapeutical Effect of Ursodeoxycholic Acid(UDCA) to Short Bowel Syndrome Patients
Condition: Short Bowel Syndrome
Intervention: Drug: ursodeoxycholic acid
18 Unknown  Magnetic Resonance (MR) Enterography Assessment of Post Operative Small Bowel Length in Short Bowel Syndrome Patients
Condition: Short Bowel Syndrome
Intervention: Radiation: Barium follow-through and MR-enterography
19 Completed A One-Year, Open-Label Study With Teduglutide for Subjects Who Completed Study CL0600-021
Condition: Short Bowel Syndrome
Intervention: Drug: Teduglutide
20 Completed Mechanisms of Adaptation in Human Short Bowel Syndrome
Condition: Short Bowel Syndrome
Intervention:

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years